• Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a highly collegial group that is dedicated to the pursuit of excellence and advancement of critical care research in Canada.
  • Canadian Critical Care Trials Group
    The CCCTG has are more than 30 research programs underway and over 100 peer-reviewed publications to its credit, with direct impact on clinical practice in critical care.
  • Canadian Critical Care Trials Group
    The Canadian Critical Care Trials Group (CCCTG) is a national organization of more than 300 individuals with research interests in the management of the critically ill patient.
  • Canadian Critical Care Trials Group
    Endorsement by the CCCTG communicates our full commitment to ensure that the work is undertaken in a rigorous and ethical manner, and communicated in a timely and effective way.


University of Manitoba Health Sciences Center



Contact This Member

Allan Garland

Allan Garland is Associate Professor in the Departments of Medicine and Community Health Sciences at the University of Manitoba. He is co-head of the Section of Critical Care Medicine, and an Adjunct Scientist at the Manitoba Centre for Health Policy.

Dr. Garland received a B.S. from the University of Michigan and M.A. from Harvard University, both in physics.  He completed his MD, Internal Medicine residency, and fellowship in Pulmonary & Critical Care Medicine at the University of Chicago, where he studied neural mechanisms in asthma.  Subsequently he has been on the Faculty at the Robert Wood Johnson Medical School in New Jersey, and Case Western Reserve University School of Medicine in Ohio.  While at those Institutions he was the Director of their Medical Intensive Care Units. 

Dr. Garland’s areas of research include: (1) the epidemiology and long-term outcomes of critical illness, (2) disparities in ICU access, (3) performance improvement in medical care, especially the relationships between clinical outcomes and ICU organization/structure, (4) variation in medical practice, (5) end-of-life care, (5) understanding and reducing use of useless and/or dangerous interventions in ICU care, and (6) statistical modeling methods.